posining with aluminium posphid. Other and unspecified agents primarily affecting the cardiovascular system
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, a Echinophora cinerea extract is obtained from a dried and powdered part of the plant is given as a suspension, to patients 40mg/kg da
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients aged 15-70 in both genders All cases of acute and chronic exposure to 6 months after the onset of symptoms Confirmation of oral intake and respiratory exposure based on history and clinical symptoms
Exclusion criteria
Exclusion criteria: Patients with receiving any medical care at other centers, before entering the emergency room or ICU Patients with underlying illness, including: diabetes, cardiovascular disease, respiratory failure, renal and hepatic dysfunctio?
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Troponin anzyme. Timepoint: 24 hours after intervention. Method of measurement: Using the Laboratory Kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver enzymes. Timepoint: at first-24-48-72 after intervention. Method of measurement: Using the Laboratory Kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfshin Nazari
Khoram-Abad University of Medical Sciences
Outcome results
None listed